How does cannabis interact with pharmaceutical drugs?

Cannabis Life Network

Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.

More Women Switch Out Pharmaceuticals For Medical Marijuana

The Fresh Toast

More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Corbus Pharmaceuticals Beats Estimates For Fourth Quarter

Cannabis Law Report

Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…

Ibere Pharmaceuticals Is The Quiet SPAC

Cannabis Law Report

While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.

Anebulo Pharmaceuticals Announces Pricing of Initial Public Offering

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More. Business Wire

Algernon Pharmaceuticals Announces 50% Enrollment of its Ifenprodil IPF and Chronic Cough Phase 2 Human Study

Cannabis Law Report

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “Company”… Read More. Cannabis Finance News

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

Cannabis Law Report

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership

Cannabis Law Report

Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Cannabis Law Report

Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire

Prohibition Partners (UK) Publish “The Pharmaceutical Cannabis Report”

Cannabis Law Report

Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More.

Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track

Cannabis Law Report

TEL AVIV, Israel and BETHESDA, Maryland, April 26, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. OTCQB: CNBX), a global leader in… Read More. Cannabis Finance News

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke

Cannabis Law Report

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics

Cannabis Law Report

The post MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics first appeared on Cannabis Law Report.

Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit

Cannabis Law Report

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.

February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 billion

Cannabis Law Report

The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV

February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion

Cannabis Law Report

The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV

GW Pharmaceuticals loses $8 million over last quarter

Cannabis Law Report

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 billion

Cannabis Law Report

The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report. Breaking News

61% of Medical Cannabis Users in Texas Said Weed Helped Them Get off Pharmaceuticals

SpeedWeed

Although this survey is specifically focused on Texas’ medical marijuana program, it also supports other research showing that cannabis can serve as an effective replacement for pharmaceuticals.

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. It is important that the pharmaceutical industry continues to work with the medical advisory body to ensure that drugs are cost effective and that its long-term effects are clear.” About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

Cannabis Law Report

Chaired by Katharine Whartenby, Ph.D., members include experts in molecular medicine, aging, pathology and oncology BALTIMORE–(BUSINESS WIRE)–Akers Biosciences, Inc. Nasdaq:… Read More. Business Wire

Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

Cannabis Law Report

VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company”… Read More. Cannabis Finance News

Canada: Mydecine signs agreement with Applied Pharmaceutical Innovation (API) at the University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences

Cannabis Law Report

The mycology-focused company has signed an agreement with Applied Pharmaceutical Innovation (API), … Read More. Mydecine ( MYCO.CN ) ( NLBIF ) is quickly upping its fungi authority.

European Pharmaceutical Company STADA and MediPharm Labs Begin First Sales in Germany Under Exclusive Agreement

Cannabis Law Report

BARRIE, Ontario, April 1, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a… Read More. Cannabis Finance News

Clever Leaves Successfully Delivers First Shipment of EU GMP certified Cannabis derived Pharmaceuticals from Colombia to Germany

Cannabis Law Report

Clever Leaves expands global capabilities and development of market specific pharmaceutical products. The post Clever Leaves Successfully Delivers First Shipment of EU GMP certified Cannabis derived Pharmaceuticals from Colombia to Germany first appeared on Cannabis Law Report.

2021 Pipeline Insights into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Scleroderma – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights… Read More. Business Wire

MyMD Pharmaceuticals Announces Issuance of Allowance from United States Patent and Trademark Office for Synthetic Cannabinoid Compounds

Cannabis Law Report

Patent protects Supera-CBD, a preclinical cannabidiol derivative that targets cannabinoid receptor type 2 for the treatment of neuroinflammatory and neurodegenerative… Read More. Business Wire

Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers

Cannabis Life Network

8, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […]. The post Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

SOURCE InMed Pharmaceuticals Inc. About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need.

Europe Cannabis and Pain Management Devices on Cancer Pain Market – Major Technology Giants in Buzz Again | Cannabis Players:, GW Pharmaceuticals, UNIMED PHARMACEUTICALS, Valeant Pharmaceuticals, Insys Therapeutics

Cannabis Law Report

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. Some of the players covered in the study are Cannabis Players:, GW Pharmaceuticals, UNIMED PHARMACEUTICALS, Valeant Pharmaceuticals, Insys Therapeutics, Axim Biotechnologies, Medical Marijuana, Zynerba, Pain Management Device Players:, Boston Scientific Crop.,

Pure Jamaican’s Pharma Division Seven10 Nears Start of Exportation of Pharmaceutical Cannabis Ingredients to Mexico With Mexican Senate’s Approval of Cannabis Legislation

Cannabis Law Report

3, 2020 /PRNewswire/ — Pure Jamaican Limited , provider of pharmaceutical cannabinoids, genetics and consumer packaged goods products in large volumes for … Read More. MIAMI , Dec.

European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs

Cannabis Law Report

The post European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs first appeared on Cannabis Law Report. Download as PDF October 05, 2020 A milestone for the global cannabis industry as STADA, in partnership with MediPharm, forges the way as a large … Read More. Press Release EU ZA

What the black market means for cannabis patents

Cannabis Life Network

1) We were curious if there is any weight to Canopy’s new infringement allegations against GW Pharmaceuticals (GWPH). A patent for CO2 extraction of cannabis has been acquired by Canopy Growth Corporation (TSX:WEED), but will small cannabis companies become potential targets? (1)

New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S.

Leaf Science

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. Taking cannabis user archetypes beyond the traditional medical/recreational binary, the study developed nine distinct cannabis consumer profiles and looked at their use of alcohol, pharmaceuticals and cannabis to gain greater insight into the full spectrum of consumer values, lifestyles and behaviours.

Benchmark Signs A Strategic Cooperation With China-Based Zejiang Yatai Pharmaceutical

Canna Newswire

To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has signed a non-binding letter of intent of strategic cooperation with China-based Zhejiang Yatai Pharmaceutical Co.,

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Cannabis Law Report

TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). It should be noted that Freia’s products are currently authorized under the framework of pharmaceutical law and not subject to the evolving, provisional regulation of cannabis. This EU pharmaceutical entity is an optimal addition to LGC.

GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product Sales

Cannabis Law Report

About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. Enquiries: GW Pharmaceuticals plc.